Analyzing Rapid Micro Biosystems (NASDAQ:RPID) and Seer (NASDAQ:SEER)
Analyzing Rapid Micro Biosystems (NASDAQ:RPID) and Seer (NASDAQ:SEER)
Rapid Micro Biosystems (NASDAQ:RPID – Get Rating) and Seer (NASDAQ:SEER – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, risk and dividends.
快速微生物系统公司(纳斯达克：RFID-GET评级)和SEER(纳斯达克：SEER-GET评级)都是小盘股医疗公司，但哪一家更好？我们将根据分析师的建议、盈利能力、估值、机构所有权、收益、风险和股息对这两家公司进行比较。
Insider & Institutional Ownership
内部人与机构所有权
61.0% of Rapid Micro Biosystems shares are held by institutional investors. Comparatively, 76.2% of Seer shares are held by institutional investors. 38.0% of Rapid Micro Biosystems shares are held by insiders. Comparatively, 18.0% of Seer shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
机构投资者持有快速微生物系统公司61.0%的股份。相比之下，SEER 76.2%的股份由机构投资者持有。快速微生物系统公司38.0%的股份由内部人士持有。相比之下，Seer 18.0%的股份由内部人士持有。强大的机构持股表明，捐赠基金、对冲基金和大型基金管理公司相信，一只股票的长期表现将好于大盘。
Valuation and Earnings
估值和收益
This table compares Rapid Micro Biosystems and Seer's revenue, earnings per share (EPS) and valuation.
此表比较了Rapid Micro BiosSystems和Seer的收入、每股收益(EPS)和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Rapid Micro Biosystems | $23.23 million | 2.28 | -$73.52 million | ($1.39) | -0.91 |
| Seer | $6.62 million | 43.53 | -$71.17 million | ($1.45) | -3.17 |
| 总收入 | 价格/销售额比 | 净收入 | 每股收益 | 市盈率 | |
| 快速微生物生物系统 | 2323万美元 | 2.28 | -7,352万美元 | ($1.39) | -0.91 |
| 先知 | 662万美元 | 43.53 | -7,117万美元 | ($1.45) | -3.17 |
Analyst Ratings
分析师评级
This is a breakdown of recent ratings and recommmendations for Rapid Micro Biosystems and Seer, as provided by MarketBeat.
这是由MarketBeat提供的对快速微生物生物系统和SEER的最近评级和推荐的细目。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Rapid Micro Biosystems | 0 | 2 | 0 | 0 | 2.00 |
| Seer | 1 | 2 | 0 | 0 | 1.67 |
| 销售评级 | 保持评级 | 购买评级 | 强劲的买入评级 | 评级分数 | |
| 快速微生物生物系统 | 0 | 2 | 0 | 0 | 2.00 |
| 先知 | 1 | 2 | 0 | 0 | 1.67 |
Rapid Micro Biosystems presently has a consensus price target of $10.00, indicating a potential upside of 693.65%. Seer has a consensus price target of $9.83, indicating a potential upside of 113.77%. Given Rapid Micro Biosystems' stronger consensus rating and higher probable upside, equities analysts clearly believe Rapid Micro Biosystems is more favorable than Seer.
Rapid Micro BiosSystems目前的共识目标价为10美元，表明潜在上涨693.65%。SEER的普遍目标价为9.83美元，表明潜在上涨113.77%。鉴于Rapid Micro BiosSystems更高的共识评级和更高的可能上行空间，股票分析师显然认为Rapid Micro BiosSystems比Seer更有利。
Risk & Volatility
风险与波动性
Rapid Micro Biosystems has a beta of 0.82, meaning that its stock price is 18% less volatile than the S&P 500. Comparatively, Seer has a beta of 1.46, meaning that its stock price is 46% more volatile than the S&P 500.
Rapid Micro BiosSystems的贝塔系数为0.82，这意味着其股价的波动性比标准普尔500指数低18%。相比之下，Seer的贝塔系数为1.46，这意味着其股价的波动性比标准普尔500指数高46%。
Profitability
盈利能力
This table compares Rapid Micro Biosystems and Seer's net margins, return on equity and return on assets.
此表比较了Rapid Micro BiosSystems和Seer的净利润率、股本回报率和资产回报率。
| Net Margins | Return on Equity | Return on Assets | |
| Rapid Micro Biosystems | -328.18% | -29.41% | -26.52% |
| Seer | -646.27% | -18.80% | -17.32% |
| 净利润率 | 股本回报率 | 资产回报率 | |
| 快速微生物生物系统 | -328.18% | -29.41% | -26.52% |
| 先知 | -646.27% | -18.80% | -17.32% |
Summary
摘要
Rapid Micro Biosystems beats Seer on 7 of the 13 factors compared between the two stocks.
快速微生物系统公司在两只股票比较的13个因素中有7个超过了Seer。
About Rapid Micro Biosystems
关于快速微生物系统
(Get Rating)
(获取评级)
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.
快速微生物技术公司是一家生命科学技术公司，在北美、欧洲和亚洲提供用于检测制药、医疗设备和个人护理产品制造中的微生物污染的产品。公司提供Growth Direct平台，包括Growth Direct系统、专有耗材、实验室信息管理系统连接软件以及全面的客户支持和验证服务。其平台可实现生物制剂、疫苗、细胞和基因疗法以及无菌注射剂等治疗方式的手动微生物质量控制(MQC)测试工作流程的自动化和现代化。该公司还提供安装和验证、技术培训和支持服务。其解决方案被用于环境监测、水测试、生物润湿和无菌释放测试应用。该公司前身为基因组图谱系统公司，并于2007年1月更名为Rapid Micro BiosSystems，Inc.。RAPID微生物生物系统公司成立于2006年，总部设在马萨诸塞州洛厄尔。
About Seer
关于Seer
(Get Rating)
(获取评级)
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
SEER，Inc.是一家生命科学公司，致力于开发和商业化产品，以破译蛋白质组的秘密。它开发了蛋白质图谱产品套件，这是一种集成的解决方案，包括消耗品、自动化仪器和软件，使研究人员能够在治疗和诊断研究以及临床试验中进行蛋白质组研究。该公司打算将其产品用于研究目的，包括学术机构、生命科学和研究实验室，以及用于非诊断和非临床目的的生物制药和生物技术公司。它与探索生命科学有限责任公司达成了一项合作协议。和索尔克生物研究所。该公司前身为Seer Biosciences，Inc.，于2018年7月更名为Seer，Inc.。SEER，Inc.成立于2017年，总部位于加利福尼亚州雷德伍德城。
Receive News & Ratings for Rapid Micro Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rapid Micro Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
接受《快速微生物系统日报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Rapid Micro BiosSystems和相关公司的最新新闻和分析师评级的每日简明摘要。